IDR 2600.0
(-1.52%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2222.46 Billion IDR | 1.87% |
2022 | 2181.64 Billion IDR | -17.74% |
2021 | 2652.25 Billion IDR | 41.58% |
2020 | 1873.37 Billion IDR | 7.4% |
2019 | 1744.27 Billion IDR | 9.03% |
2018 | 1599.75 Billion IDR | 9.12% |
2017 | 1466.01 Billion IDR | 7.9% |
2016 | 1358.66 Billion IDR | 13.44% |
2015 | 1197.72 Billion IDR | 8.78% |
2014 | 1101.04 Billion IDR | 10.33% |
2013 | 997.98 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 486.85 Billion IDR | -20.2% |
2024 Q3 | 566.15 Billion IDR | 3.8% |
2024 Q2 | 545.43 Billion IDR | 12.03% |
2023 Q2 | 545.24 Billion IDR | 5.29% |
2023 Q1 | 517.82 Billion IDR | -13.93% |
2023 FY | 2222.46 Billion IDR | 1.87% |
2023 Q4 | 610.1 Billion IDR | 11.07% |
2023 Q3 | 549.29 Billion IDR | 0.74% |
2022 Q2 | 480.93 Billion IDR | -13.51% |
2022 Q1 | 556.07 Billion IDR | -15.95% |
2022 FY | 2181.64 Billion IDR | -17.74% |
2022 Q3 | 542.98 Billion IDR | 12.9% |
2022 Q4 | 601.64 Billion IDR | 10.8% |
2021 Q2 | 612.82 Billion IDR | -2.03% |
2021 Q3 | 752.29 Billion IDR | 22.76% |
2021 Q4 | 661.61 Billion IDR | -12.05% |
2021 FY | 2652.25 Billion IDR | 41.58% |
2021 Q1 | 625.53 Billion IDR | -6.82% |
2020 Q4 | 671.29 Billion IDR | 23.22% |
2020 Q1 | 391.37 Billion IDR | -22.56% |
2020 Q2 | 265.91 Billion IDR | -32.06% |
2020 Q3 | 544.78 Billion IDR | 104.87% |
2020 FY | 1873.37 Billion IDR | 7.4% |
2019 Q3 | 439.8 Billion IDR | 10.06% |
2019 Q4 | 505.37 Billion IDR | 14.91% |
2019 Q2 | 399.61 Billion IDR | 0.03% |
2019 Q1 | 399.47 Billion IDR | -17.3% |
2019 FY | 1744.27 Billion IDR | 9.03% |
2018 Q4 | 483.06 Billion IDR | 19.54% |
2018 Q3 | 404.1 Billion IDR | 13.46% |
2018 Q2 | 356.15 Billion IDR | -0.08% |
2018 Q1 | 356.43 Billion IDR | -15.98% |
2018 FY | 1599.75 Billion IDR | 9.12% |
2017 Q4 | 424.22 Billion IDR | 14.91% |
2017 FY | 1466.01 Billion IDR | 7.9% |
2017 Q3 | 369.17 Billion IDR | 8.25% |
2017 Q2 | 341.04 Billion IDR | 2.86% |
2017 Q1 | 331.56 Billion IDR | -19.72% |
2016 Q1 | 311.37 Billion IDR | 2.67% |
2016 Q2 | 337.25 Billion IDR | 8.31% |
2016 Q3 | 297.02 Billion IDR | -11.93% |
2016 Q4 | 413.01 Billion IDR | 39.05% |
2016 FY | 1358.66 Billion IDR | 13.44% |
2015 Q2 | 295.58 Billion IDR | -0.0% |
2015 Q4 | 303.27 Billion IDR | 0.0% |
2015 FY | 1197.72 Billion IDR | 8.78% |
2015 Q1 | 295.58 Billion IDR | 0.0% |
2015 Q3 | 303.27 Billion IDR | 2.6% |
2014 FY | 1101.04 Billion IDR | 10.33% |
2013 FY | 997.98 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Diagnos Laboratorium Utama Tbk | 145.69 Billion IDR | -1425.413% |